State Of New Jersey Common Pension Fund D Sage Therapeutics, Inc. Transaction History

State Of New Jersey Common Pension Fund D

$32.6 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$16.75 - $48.98 $1.31 Million - $3.83 Million	78,292 Added 161.76%	126,693 $2.61 Million
Q2 2023 Aug 02, 2023	SELL	$40.65 - $59.54 $269,265 - $394,392	-6,624 Reduced 12.04%	48,401 $2.28 Million
Q1 2023 Apr 26, 2023	SELL	$37.27 - $46.57 $183,032 - $228,705	-4,911 Reduced 8.19%	55,025 $2.31 Million
Q3 2022 Oct 28, 2022	SELL	$32.28 - $43.27 $319,507 - $428,286	-9,898 Reduced 14.17%	59,936 $2.35 Million
Q2 2022 Aug 04, 2022	SELL	$27.52 - $37.99 $121,308 - $167,459	-4,408 Reduced 5.94%	69,834 $2.26 Million

Q1 2022 May 03, 2022	BUY	$30.71 - $45.71 $171,085 - $254,650	5,571 Added 8.11%	74,242 $2.46 Million
Q4 2021 Jan 31, 2022	BUY	$37.06 - $47.11 $121,371 - $154,285	3,275 Added 5.01%	68,671 $2.92 Million
Q3 2021 Oct 27, 2021	BUY	$40.26 - $57.37 $1.22 Million - $1.74 Million	30,354 Added 86.62%	65,396 $2.9 Million
Q2 2021 Jul 23, 2021	BUY	$54.88 - $79.29 $62,947 - $90,945	1,147 Added 3.38%	35,042 $1.99 Million
Q1 2021 Apr 27, 2021	SELL	$70.65 - $96.76 $119,822 - $164,104	-1,696 Reduced 4.77%	33,895 $2.54 Million
Q4 2020 Feb 03, 2021	SELL	$58.41 - $89.06 $749,400 - $1.14 Million	-12,830 Reduced 26.5%	35,591 $3.08 Million
Q3 2020 Oct 27, 2020	SELL	$41.13 - $62.45 $177,763 - $269,908	-4,322 Reduced 8.19%	48,421 $2.96 Million
Q2 2020 Aug 04, 2020	BUY	$25.95 - $43.15 $369,009 - $613,593	14,220 Added 36.91%	52,743 $2.19 Million
Q4 2019 Jan 31, 2020	SELL	$60.18 - $154.77 $94,903 - $244,072	-1,577 Reduced 3.93%	38,523 $2.78 Million
Q3 2019 Oct 23, 2019	BUY	$140.29 - $189.96 $3.52 Million - $4.77 Million	25,100 Added 167.33%	40,100 $5.63 Million
Q1 2019 May 02, 2019	BUY	$89.33 - $163.65 $893,300 - $1.64 Million	10,000 Added 200.0%	15,000 $2.39 Million
Q1 2018 May 08, 2018	BUY	$152.15 - $192.33 $760,750 - $961,650	5,000 New	5,000 $805,000

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$62 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$59.1 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$52.7 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$51.2 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$48.5 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.

Account